With the first CONSIGMA™ barely installed at a Top-10 pharmaceutical
company for production of a blockbuster drug, Collette has received a second
order for this innovative continuous high-shear granulation and drying system
from another Top-10 company for development of new medicines.
The main
driver for this company to select the CONSIGMA™ technology is the fact that
there is no need for scale-up with this technology, as the difference between R
& D batches and production batches is the time during which the machine
runs. This has another advantage that this company deemed very important, which
is the fact that CONSIGMA™ can produce any batch size needed.
For more
information about these and other advantages, please visit www.consigma.be or contact
Collette.